On 30 June 2022 and 25 August 2022, the applicant informed the Commission about its interest in other representative biocidal products for the evaluation of ethylene oxide for use in biocidal products of product-type 2 within the scope of Regulation (EU) No 528/2012: (i) for the sterilisation of medicinal products; (ii) for the sterilisation of packaging intended for medicinal products, but without the product itself being present during sterilisation, and (iii) for the sterilisation of ‘combination products’. The applicant asked the Commission whether such uses are within the scope of Regulation (EU) No 528/2012.
Recital 12, Decision_act (EU) 2025/1074
In forcesince 2 Jun 2025